PillRx only · Capsule · Oral
Lubiprostone
Lubiprostone
5 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US10 NDCs
5 active makers
5 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)—
US makers5 labelers
Packages20
DEA / ScheduleNone
US acquisition costNADAC · per unit
Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.625
Latest avg · Jun 17, 2026
-16%
Since Dec 17, 2025
5
Active US suppliers
60%
Top-2 supplier share*
Medicaid dispensing volume
No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.
Who makes it5 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Asclemed USA, Inc. | unknown | 8 | SUPPLYING |
| Zydus Lifesciences Limited | unknown | 4 | SUPPLYING |
| Zydus Pharmaceuticals USA Inc. | unknown | 4 | SUPPLYING |
| NorthStar Rx LLC | unknown | 2 | SUPPLYING |
| Camber Pharmaceuticals, Inc. | unknown | 2 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.